Complement and Coagulation

Summary

Serum β1c- β1a was found to be significantly depressed in 16 of 27 patients with disseminated intravascular coagulation. In vitro studies supported the finding that the serum β1c- β1a of urokinase-treated patients was not altered by fibrinolytic therapy. This strongly suggests that plasmin is not responsible for the low C3.

^* Present Address : Department of Medicine Upstate Medical Center Syracuse, New York 13210.

• References

• 1 Alper C. A, Abramson N, Johnston R. B, Jendl J. H, Rosen F. S. Increased susceptibility to infection associated with abnormalities of complement mediated functions and of the third component of complement (C3). New Engl. J. Med 282: 349 1970;
• 2 Biggs R, MacFarlane R. G. Human Blood Coagulation. 11 391-393 Blackwell Scientific Publications; Oxford: 1962
• 3 Brodsky I, Ross E, Reid W. O. The use of the serial thrombin time in evaluating therapy with epsilon aminocaproic acid in massive thrombolysis and proteolysis. Amer. J. clin. Path 41: 589 1964;
• 4 Gewürz H, Shin H, Mergenhagen S. E. Interactions of the complement system with endotoxic lipopolysaccharide : Consumption of each of the six terminal complement components. J. exp. Med 128: 1048 1968;
• 5 Grieco M. H, Capra J. D, Paderon H. Reduced Serum Beta lc/la Globulin Levels in Extrarenal Diseases. Amer. J. Med 51: 340 1971;
• 6 Kohler P. R, Muller-Eberhard H. J. Immunochemical quantitation of the third, fourth, and fifth components of human complement: concentrations in the serum of healthy adults. J. Immunol 99: 1211 1967;
• 7 Lundh B. Studies on serum ßlc-Globulin. Acta Universitatis Lundensis. II, no. 27, 1965
• 8 Mayer M. M. Complement and complement fixation. In: Kabat and Mayer, Experimental Immunochemistry. 133-153 Charles C. Thomas; Springfield: 1961
• 9 McKay D. G. Disseminated Intravascular Coagulation. Hoeber Medical Division, Harper and Row; New York: 1965. 212 247.
• 10 Mellman W. J, Wolman I. J, Wurzel H. A, Moorhead P. S, Qualls D. H. A chromosomal female with hemophilia A. Blood 17: 719 1962;
• 11 Mertens B. F, McDuffie F. G, Bowie E. J, Owen G. A. Rapid sensitive method for measuring fibrinogen split products in human serum. Mayo Clin. Proc 44: 114 1969;
• 12 Miller M. E, Nilsson U. R. A familial deficiency of the phagocytosis enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). New Engl. J. Med 282: 254 1970;
• 13 Ouchterlony O. Diffusion-in-gel methods for immunological analyses II. Prog. Allergy. vol. 6, 30-107 Karger, Basel/München; New York: 1965
• 14 Rake M. O, Flute P. T, Pannell G, Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet. 533. (March 14, 1970).
• 15 Taylor Jr. F. B, Muller-Eberhard H. J. Factors influencing lysis of whole blood clots. Nature 216: 1023 1967;
• 16 Tomar R. H, Taylor Jr. F. B. The Streptokinase-Human Plasminogen Activator Complex. Biochem. J 125: 793 1971;
• 17 Ward P. A. A plasmin-split fragment of C3 as a new chemotatic factor. J. exp. Med 126: 189 1967;
• 18 Zimmerman T. S, Muller-Eberhard H. J. Blood coagulation initiated by a complementmediated pathway. J. exp. Med 134: 1601 1971;